Patent details

EP1093517 Title: Antigenen en preparaten van Neisseria meningitidis.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1093517
WO Application Number:
US1999009346
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP99922752.3
WO Publication Number:
WO1999057280
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
30/04/1999
Grant date:
05/03/2008
EP Publication Date:
05/03/2008
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/05/2018
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/03/2008
EP B1 Publication Date:
05/03/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/04/2019
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
03/05/2017
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

From:
03/05/2017
 
 

 

Name:
J. Craig Venter Institute, Inc.
Address:
9704 Medical Center Drive, 20850, Rockville, Maryland, United States of America (US)

Historical Applicant/holder

From:
29/10/2008
To:
03/05/2017

 

Name:
Novartis Vaccines and Diagnostics, Inc.
Address:
4560 Horton Street, 94608-2916, Emeryville, California, United States of America (US)

From:
29/10/2008
To:
03/05/2017

 

Name:
J. Craig Venter Institute, Inc.
Address:
9704 Medical Center Drive, 20850, Rockville, Maryland, United States of America (US)

From:
05/03/2008
To:
29/10/2008

 

Name:
Novartis Vaccines and Diagnostics, Inc.
Address:
4560 Horton Street, 94608-2916, Emeryville, California, United States of America (US)

From:
05/03/2008
To:
29/10/2008

 

Name:
THE INSTITUTE FOR GENOMIC RESEARCH
Address:
9212 Medical Center Drive, 20850, Rockville, Maryland, United States of America (US)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
05/03/2008
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Claire FRASER
Address:
MD 20850, Rockville, United States of America (US)

2

Name:
Cesira GALEOTTI
Address:
53100, Siena, Italy (IT)

3

Name:
Guido GRANDI
Address:
53100, Siena, Italy (IT)

4

Name:
Erin HICKEY
Address:
MD 20850, Rockville, United States of America (US)

5

Name:
Vega MASIGNANI
Address:
53100, Siena, Italy (IT)

6

Name:
Mariarosa MORA
Address:
53100, Siena, Italy (IT)

7

Name:
Jeremy PETERSEN
Address:
MD 20850, Rockville, United States of America (US)

8

Name:
Mariagratia PIZZA
Address:
53100, Siena, Italy (IT)

9

Name:
Rino RAPPUOLI
Address:
53100, Siena, Italy (IT)

10

Name:
Giulio RATTI
Address:
53100, Siena, Italy (IT)

11

Name:
Enzo SCALATO
Address:
53100, Siena, Italy (IT)

12

Name:
Maria SCARSELLI
Address:
53100, Siena, Italy (IT)

13

Name:
Hervé TETTELIN
Address:
MD 20850, Rockville, United States of America (US)

14

Name:
J., Craig VENTER
Address:
MD 20850, Rockville, United States of America (US)

Priority

1

Priority Patent Number:
99062 P
Priority Date:
02/09/1998
Priority Country:
United States of America (US)

2

Priority Patent Number:
98994 P
Priority Date:
02/09/1998
Priority Country:
United States of America (US)

3

Priority Patent Number:
94869 P
Priority Date:
31/07/1998
Priority Country:
United States of America (US)

4

Priority Patent Number:
83758 P
Priority Date:
01/05/1998
Priority Country:
United States of America (US)

5

Priority Patent Number:
121528 P
Priority Date:
25/02/1999
Priority Country:
United States of America (US)

6

Priority Patent Number:
103796 P
Priority Date:
09/10/1998
Priority Country:
United States of America (US)

7

Priority Patent Number:
103794 P
Priority Date:
09/10/1998
Priority Country:
United States of America (US)

8

Priority Patent Number:
103749 P
Priority Date:
09/10/1998
Priority Country:
United States of America (US)

Classification

Main IPC Class:
C12N 15/31;
IPC or IDT classification:
A61K 39/095; C07K 14/22; C07K 16/12; C12Q 1/68; G01N 33/50;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
50/18
Publication date:
05/12/2018
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
30/17
Publication date:
26/07/2017
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
2009/01
Publication date:
05/01/2009
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
MED
Journal edition number:
2008/11
Publication date:
03/11/2008
Description:
Other communications

5

Bulletin Heading:
EP3
Journal edition number:
2008/08
Publication date:
01/08/2008
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2008/05
Publication date:
01/05/2008
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200810
Publication date:
05/03/2008
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201700993B
Date Registered:
03/05/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

2

Name:
J. Craig Venter Institute, Inc.
Address:
9704 Medical Center Drive, 20850, Rockville, Maryland, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
52640-A052640-1
Date Registered:
29/10/2008
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
18/04/2017
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
21/07/2017 Outgoing Correspondence Letter registration deed 2 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_6_151768l118.pdf
03/05/2017 Request for Change First filed deed 3 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_0_rfc20170531112953333.pdf
03/06/2008 Drawings First filed drawings 5 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_1_drawings20080603.pdf
03/06/2008 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_2_incomingcorrespondencepaper20080603.pdf
03/06/2008 Description Translated description 110 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_3_description20080603.pdf
03/06/2008 Incoming Correspondence Paper Correspondence address details 1 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_5_incomingcorrespondencepaper20080603.pdf
03/06/2008 Claims Translated claims 4 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_7_claims20080603.pdf
26/02/2008 Incoming Correspondence Paper Other 1 PDF /2/5/7/2/2/0599922752/docs/ep99922752.3_4_incomingcorrespondencepaper20080226.pdf